World News | Reuters | Wednesday December 9, 2020
Britain's medical regulator will examine all the data from trials of the COVID-19 vaccine developed by Oxford and AstraZeneca, including which dosing regimen is best to use, the regulator's chief executive said on Wednesday.
www.ndtv.com